- $3.51bn
- $15.87bn
- $2.11bn
- 69
- 52
- 80
- 74
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,715 | 1,406 | 1,420 | 1,976 | 2,106 |
Cost of Revenue | |||||
Gross Profit | 915 | 972 | 1,135 | 1,377 | 1,041 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,538 | 955 | 918 | 1,467 | 2,032 |
Operating Profit | 177 | 450 | 502 | 509 | 74.2 |
Net Income Before Taxes | 177 | 450 | 502 | 509 | 74.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | 141 | 350 | 386 | 396 | 54.4 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 142 | 352 | 393 | 407 | 91.5 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 140 | 347 | 387 | 400 | 89.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.88 | 4.25 | 10.2 | 11 | 3.02 |
Dividends per Share |